Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Olive oil bra cup may improve healing after breast reduction

NCT ID NCT06420323

Symptom relief Sponsor: MOSS S.p.A. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new wound dressing called NovoX Cup, a bra-shaped cup coated with oxygen-enriched olive oil, for healing after breast reduction surgery. Twenty women will have one breast treated with the new cup and the other with standard dressings to compare scar quality, pain, and complications at 2 weeks and 3 months. The goal is to see if the cup improves healing without side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2024

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Female patients undergoing elective bilateral breast reduction surgery.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Written informed consent * Female patients 18 years and older * Patient able to give informed consent * Patients undergoing bilateral breast reduction Exclusion Criteria: * Absent informed consent * Patients from protected groups and those who are not personally able to give consent. * Patients younger than 18 years * Pregnancy (pregnancy test before enrollment) and breastfeeding women * Former radiation of the breast(s) * Former surgery at the operation site * Skin abnormalities in the operation area (e.g. burn scars) * Participation in other clinical trials during this study * Active malignant disease * Breast cancer history * Radiation or chemotherapy during the study period or up to 6 months before possible enrollment * Immune disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mammaplasty are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Postoperative Complications Surgical Wound

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mammaplasty Post-surgical complication Wound healing disorder

Contacts and locations

Locations

  • Division of Plastic, Aesthetic & Reconstructive Surgery, Department of Surgery, Medical University of Graz

    Graz, A-8036, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.